Please login to the form below

White Paper for download - Explaining the price of your product

In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step.

Are you struggling to defend the price of your product?

With around 40 years’ experience in the pharmaceutical industry and over 30 years in global market access, Valid Insight’s Senior Executive Advisor, Raf De Wilde, shares his expert insight and experiences to help guide you in explaining the price of your product.

In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step.

Download now for insight into:

  • Why pharma needs to do a better job at explaining prices
  • Explaining and justifying your price internally, to your boss, and to authorities
  • How low product differentiation leads to price referencing
  • If cost-plus pricing applies
  • A value-based pricing option
  • What is entrepreneurial pricing
  • Base principles that can help define better prices
  • How to follow price finding with price implementation

Download the white paper here: https://www.validinsight.com/resource-center/explaining-the-price-of-your-product/

22nd January 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines.
Valid Insight
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the evaluation of health and healthcare interventions.
Valid Insight
Pricing and Market Access Simulator
Reliable tool for value assessment of pipeline products
Valid Insight
Virtual workshops to elevate value, pricing and market access strategies
This blog post explores how well-facilitated virtual workshops can be just as valuable as face-to-face meetings.
Valid Insight
Putting people and the planet first in 2020
Valid Insight go paperless to promote environmental sustainability within the pharmaceutical industry
Valid Insight
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to get a return on investment.  What are the implications for pharma and biotech market access?
Valid Insight